Low Cost Technologies for Global Health
NCI has released a new funding opportunity.
Descriptions of upcoming events can be found here.
NCI’s Center for Global Health is working to increase the availability of low-cost, portable technologies for cancer diagnosis, imaging, and treatment in low- and middle-income countries (LMICs). The technical scope of our efforts is broad, but we are interested in several key specifications for the technologies we would like to see developed. Read more about the objectives here.
Two-thirds of cancer deaths occur in low- and middle income countries. Access to cancer prevention, screening, detection, diagnosis and treatment are major challenges in LMICs, especially in rural areas with limited infrastructure.
CGH supports development and validation of technologies with the potential to increase early detection, diagnosis, and non-invasive or minimally invasive treatment of cancer. Many of these technologies have the potential to be developed into low-cost, portable, point-of-care versions useful in resource-constrained settings, including:
In vitro diagnostics
- Lab-on-a-Chip (LOC)/ Paper-based microfluidics
- Dipstick/Paper-based tests
- New surgical devices
- Laser therapy
- Radiofrequency ablation
- Low-power-density sonication
- High-intensity focused ultrasound (HIFU)
- Photodynamic therapy
The Center for Global Health is currently developing strategies to support mobile health (mHealth) technologies and mHealth initiatives for low- and middle-income countries. CGH is looking to expanding upon these strategies in 2014.